Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to the newest version of your browser.

Your browser appears to have cookies disabled. For the best experience of Construction News, please enable cookies in your browser.

Welcome to the Construction News site. As we have relaunched, you will have to sign in once now and agree for us to use cookies, so you won't need to log in each time you visit our site.
Learn more

Drug deal


Just Laing O'Rourke and Skanska are left in the chase to build a £20 million pharmaceutical facility in Surrey after Amec and Bovis Lend Lease were dropped. The work for Eli Lilly involves building new laboratories at Windlesham and will start next month.